[Clinical evaluation of cephalexin monohydrate in the treatment of pyelonephritis].
D000328:Adult; D000368:Aged; D002511:Cephalosporins / Q000627:therapeutic use*; D004035:Diet Therapy; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D004927:Escherichia coli Infections / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009397:Nephrocalcinosis / Q000209:etiology; D011704:Pyelonephritis / Q000150:complications / Q000188:drug therapy*; D012480:Salmonella Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D014555:Urination Disorders / Q000209:etiology
D002511:Cephalosporins
Valoración clínica del monohidrato de cefalexina en el tratamiento de la pielonefritis.